At the Society of Thoracic Surgeons (STS) annual meeting, it was standing room only at a session dedicated to why the ...
Mild tricuspid valve regurgitation isn’t usually a cause for alarm, especially if you don’t have anatomical issues. About 80% of the population has mild asymptomatic tricuspid regurgitation ...
Mount Carmel’s heart and vascular teams have debuted several new, highly advanced surgical procedures in Central Ohio.
Discover how heart centers across the country are improving patient outcomes and reducing mortality rates through innovative approaches and advanced therapies.
For the full calendar of 2024, Abbott recorded sales of $41.95 billion, following the launches last year of a new heart valve ...
Transcatheter tricuspid-valve replacement may improve outcomes. New research findings are summarized in a short video.
UCLA currently offers Tricuspid Valve TEER to appropriate patients with severe tricuspid regurgitation in the clinical trial setting, and actively enrolls patients in the CLASP II TR trial of the ...
The global heart valve frame market is poised for significant growth over the coming years, driven by factors such as increasing prevalence of cardiovascular ...